Skip to contentS
Skinvisible, Inc.
S
SKVISkinvisible, Inc. Q1 2026 · 10-Q
Revenue$5.00K$5.00K±0.0% vs Q1 2025 Net Income-$267.18K-$267.18KN/M vs Q1 2025 EPS, diluted—
Operating Income-$125,938N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skinvisible, Inc. · CIK 1085277 · Engraved from SEC EDGAR
Operating Cash Flow-$822N/M Margins · derivedGross margin100.0%±0.0 pt vs Q1 2025
Operating margin-2518.8%+278.3 pt vs Q1 2025
Net margin-5343.7%+276.4 pt vs Q1 2025
ended Mar 31, 2026 · filed May 13, 2026 · 43 d after period end